CD274 and gastric cancer: Moreover, although effective in first-line treatment of hepatocellular carcinoma, the combination of anti-VEGF and anti-PD-1/PD-L1 agents (which will be discussed in the next section of this review) has yet to be studied in first-line treatment of advanced GEJ and GC [27].